NCGR, Simbiot join forces to create new solutions for handling genomic data

NewsGuard 100/100 Score

On Tuesday, the National Center for Genome Resources and Simbiot announced a strategic partnership to create new solutions for handling 'big data' in the genomics space.

The two groups are joining forces to launch Lumenogix NGS, a software platform that offers researchers unprecedented knowledge mining and control over their own next-generation sequencing data.

"We are excited to partner with Simbiot and help researchers handle genomic data on their own without specialized bioinformatics expertise," said Dr. Callum Bell, President of NCGR. "Working together we will deliver new and exciting solutions that connect NCGR's expertise and over 20 years in bioinformatics with Simbiot's innovative technical solutions."

"Today is about putting customers first," said Dr. Boris Umylny, CEO of Simbiot. "Together with NCGR we will deliver applications that solve significant technical challenges inherent in high-throughput biological data."

Lumenogix NGS includes:

  • Data analysis capability with five integrated pipelines and dozens of peer-reviewed algorithms.
  • Researcher-friendly interface allowing non-specialists to easily analyze complex data sets.
  • Data and information management, tracking samples through all steps of the data analysis process.
  • Painless integration with corporate IT infrastructure and regulatory environments.

Lumenogix NGS is available in three configurations:

  • Individual researcher accounts – hosted on NCGR's secure, private cloud,
  • Private servers that run on computer infrastructure of customer's choice and
  • Appliance – a hardware/software solution that provides customers with turnkey hardware and bioinformatic infrastructure.

SOURCE NCGR

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity